Impact of Medical Comorbidity in Biomarker Discovery for Major Depressive Disorder.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 6, p. 239, doi. 10.3928/00485713-20200507-02
- By:
- Publication type:
- Article
Works matching IS 00485713 AND DT 2020 AND VI 50 AND IP 6
Results: 8
1
2
Prednisone-Induced Psychosis, and Homicidal and Suicidal Attempts in a Man Recently Diagnosed with Temporal Arteritis.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
3
Mapping Immune System Dysfunction to Provide Clinically Actionable Biomarkers and to Understand Psychiatric Pathology.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 6, p. 244, doi. 10.3928/00485713-20200506-01
- By:
- Publication type:
- Article
4
The Promise of Biomarkers for Psychiatry.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
5
Telepsychiatry in the Time of COVID-19: Shattering Assumptions.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
6
Personal Devices and Smartphone Applications for Detection of Depression.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 6, p. 255, doi. 10.3928/00485713-20200505-01
- By:
- Publication type:
- Article
7
Mania with Psychosis Induced by Low-Dose Trazodone.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
8
Pathology-Congruent Biases as Biomarkers for Psychopathology.
- Published in:
- Psychiatric Annals, 2020, v. 50, n. 6, p. 250, doi. 10.3928/00485713-20200504-01
- By:
- Publication type:
- Article